INTEC PHARMA LTD. Research And Development Expense
INTEC PHARMA LTD. reported Research And Development Expense of $8.40 million for the 3-month period ending 2018-06-30, per its 6-K filed 2018-08-15.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2018-08-15
- INTEC PHARMA LTD. research and development expense for the quarter ending 2018-06-30 was $8.40M, a 49.44% increase year-over-year.
- INTEC PHARMA LTD. research and development expense for the quarter ending 2017-06-30 was $5.62M.
| Period end | Research And Development Expense 3 month | Research And Development Expense 6 month | Research And Development Expense 12 month |
|---|---|---|---|
| 2018-06-30 | $8.40M 6-K · filed 2018-08-15 | $17.28M 6-K · filed 2018-08-15 | |
| 2017-12-31 | $24.30M 20-F · filed 2018-03-09 | ||
| 2017-06-30 | $5.62M 6-K · filed 2018-08-15 | $9.54M 6-K · filed 2018-08-15 | |
| 2016-12-31 | $10.75M 20-F · filed 2018-03-09 | ||
| 2015-12-31 | $4.82M 20-F · filed 2018-03-09 |